173 related articles for article (PubMed ID: 25572961)
1. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T
World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961
[TBL] [Abstract][Full Text] [Related]
2. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
3. Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer.
Ahopelto K; Böckelman C; Hagström J; Koskensalo S; Haglund C
Cancer Biol Ther; 2016; 17(2):163-8. PubMed ID: 26650256
[TBL] [Abstract][Full Text] [Related]
4. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
5. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
[TBL] [Abstract][Full Text] [Related]
6. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer.
Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G
Digestion; 2013; 88(3):182-92. PubMed ID: 24193262
[TBL] [Abstract][Full Text] [Related]
8. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
[TBL] [Abstract][Full Text] [Related]
9. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients.
Song Y; Liu D; He G
Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948
[TBL] [Abstract][Full Text] [Related]
10. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
[TBL] [Abstract][Full Text] [Related]
11. Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis.
da Costa IA; Hennenlotter J; Stühler V; Kühs U; Scharpf M; Todenhöfer T; Stenzl A; Bedke J
Urol Oncol; 2018 Oct; 36(10):472.e21-472.e27. PubMed ID: 30119993
[TBL] [Abstract][Full Text] [Related]
12. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A
Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
Latz S; Umbach T; Goltz D; Kristiansen G; Müller SC; Ellinger J
Urol Int; 2016; 96(1):39-45. PubMed ID: 26287745
[TBL] [Abstract][Full Text] [Related]
14. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression.
Kayser G; Sienel W; Kubitz B; Mattern D; Stickeler E; Passlick B; Werner M; Zur Hausen A
Pathology; 2011 Dec; 43(7):719-24. PubMed ID: 22027741
[TBL] [Abstract][Full Text] [Related]
15. TKTL1 expression in human malign and benign cell lines.
Kämmerer U; Gires O; Pfetzer N; Wiegering A; Klement RJ; Otto C
BMC Cancer; 2015 Jun; 15():2. PubMed ID: 26187043
[TBL] [Abstract][Full Text] [Related]
16. Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
Ahopelto K; Laitinen A; Hagström J; Böckelman C; Haglund C
Oncology; 2020; 98(9):643-652. PubMed ID: 32434192
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases.
Zerilli M; Amato MC; Martorana A; Cabibi D; Coy JF; Cappello F; Pompei G; Russo A; Giordano C; Rodolico V
Cancer; 2008 Sep; 113(5):936-44. PubMed ID: 18615628
[TBL] [Abstract][Full Text] [Related]
18. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
[TBL] [Abstract][Full Text] [Related]
19. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas.
Völker HU; Hagemann C; Coy J; Wittig R; Sommer S; Stojic J; Haubitz I; Vince GH; Kämmerer U; Monoranu CM
Am J Clin Pathol; 2008 Jul; 130(1):50-7. PubMed ID: 18550470
[TBL] [Abstract][Full Text] [Related]
20. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis.
Ahn WS; Crown SB; Antoniewicz MR
Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
